Individualised assessment of response to clopidogrel in patients presenting with acute coronary syndromes: A role for short thrombelastography?

Cardiovascular Therapeutics

Volumn 28, Issue 3, 2010, Pages 139-146

  Cotton, J M ^a   Worrall, A M ^a   Hobson, A R ^b   Smallwood, A ^a   Amoah, V ^a   Dunmore, S ^c   Nevill, A M ^c   Rajendra, R ^c   Vickers, J ^c   Curzen, N ^b  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b Wessex Cardiology   (United Kingdom)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Angina; Clopidogrel; Flow Cytometry; Platelet; Thrombelastography; VASP; Verify Now

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PROTON PUMP INHIBITOR; VASODILATOR STIMULATED PHOSPHOPROTEIN; ACTIN BINDING PROTEIN; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; PHOSPHOPROTEIN; TICLOPIDINE; VASODILATOR-STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; AUTOANALYZER; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MONITORING; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOELASTOGRAPHY; UNSTABLE ANGINA PECTORIS; AGED; ANALOGS AND DERIVATIVES; BLOOD; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECTS; MIDDLE AGED; PHOSPHORYLATION; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; STENT; THROMBOCYTE AGGREGATION; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED KINGDOM; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CORONARY ARTERY BYPASS; DRUG MONITORING; ENGLAND; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STENTS; THROMBELASTOGRAPHY; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952168292     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2010.00156.x     Document Type: Article

References (31)

1. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 2001 358 : 527 533.
2. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 345 : 494 502.
3. Hochholzer W, Trenk D, Bestehorn HP, et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 2006 48 : 1742 1750.
4. Cuisset T, Frere C, Quilici J, et al. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes. Thromb Haemost 2007 97 : 282 287.
5. Marcucci R, Gori AM, Paniccia R, et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up. Circulation 2009 119 : 237 242.
6. Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004 109 : 3171 3175.
7. Price MJ, Endemann S, Gollapudi RR, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008 29 : 992 1000.
8. Gurbel PA, Bliden KP, Samara W, et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: Results of the CREST Study. J Am Coll Cardiol 2005 46 : 1827 1832.
9. Barragan P, Bouvier JL, Roquebert PO, et al. Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheter Cardiovasc Interv 2003 59 : 295 302.
10. Buonamici P, Marcucci R, Migliorini A, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 2007 49 : 2312 2317.
11. Hobson AR, Petley G, Morton G, Dawkins KD, Curzen NP. Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy. Thromb J 2008 doi :.
12. Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005 46 : 1820 1826.
13. Jaremo P, Lindahl TL, Fransson SG, Richter A. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med 2002 252 : 233 238.
14. Bonello L, Paganelli F, rpin-Bornet M, et al. Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost 2007 5 : 1630 1636.
15. Frere C, Cuisset T, Morange PE, et al. Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome. Am J Cardiol 2008 101 : 1088 1093.
16. Frere C, Cuisset T, Quilici J, et al. ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. Thromb Haemost 2007 98 : 838 843.
17. Cuisset T, Hamilos M, Sarma J, et al. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol 2008 101 : 1700 1703.
18. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001 12 : 327 337.
19. Kang YG, Martin DJ, Marquez J, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985 64 : 888 896.
20. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003 96 : 51 57.
21. Hobson AR, Petley GW, Dawkins KD, Curzen N. A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography. Platelets 2007 18 : 497 505.
22. Hobson AR, Agarwala RA, Swallow RA, Dawkins KD, Curzen NP. Thrombelastography: Current clinical applications and its potential role in interventional cardiology. Platelets 2006 17 : 509 518.
23. Swallow RA, Agarwala RA, Dawkins KD, Curzen NP. Thromboelastography: Potential bedside tool to assess the effects of antiplatelet therapy? Platelets 2006 17 : 385 392.
24. Hobson AR, Qureshi Z, Banks P, Petley G, Curzen N. Effects of clopidogrel on ''Aspirin Specific" pathways of platelet inhibition. Platelets 2009 20 : 386 390.
25. Geisler T, Langer H, Wydymus M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 2006 27 : 2420 2425.
26. Bliden KP, Dichiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: Is the current antiplatelet therapy adequate? J Am Coll Cardiol 2007 49 : 657 666.
27. Angiolillo DJ, Bernardo E, Sabate M, et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2007 50 : 1541 1547.
28. Patti G, Nusca A, Mangiacapra F, Gatto L, D'ambrosio A, Di SG. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol 2008 52 : 1128 1133.
29. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007 357 : 2001 2015. (Pubitemid 350106708) (Pubitemid 350106708)
30. Brandt JT, Payne CD, Wiviott SD, et al. A comparison of prasugrel and clopidogrel loading doses on platelet function: Magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 2007 153 : 66.e9 66.e16.
31. Matetzky S, Fefer P, Shenkman B, Varon D, Savion N, Hod H. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction. Am J Cardiol 2008 102 : 524 549.